SG Americas Securities’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
+16,051
New +$212K ﹤0.01% 2722
2025
Q4
Sell
-13,766
Closed -$255K 3623
2025
Q3
$255K Sell
13,766
-62,536
-82% -$982K ﹤0.01% 2592
2025
Q2
$1.22M Sell
76,302
-229,985
-75% -$4.1M 0.01% 1035
2025
Q1
$5.95M Buy
306,287
+96,758
+46% +$2.04M 0.02% 427
2024
Q4
$4.62M Buy
209,529
+200,591
+2,244% +$3.86M 0.02% 368
2024
Q3
$151K Sell
8,938
-42,562
-83% -$632K ﹤0.01% 2725
2024
Q2
$615K Sell
51,500
-381
-0.7% -$4.26K ﹤0.01% 1559
2024
Q1
$575K Buy
51,881
+13,392
+35% +$137K ﹤0.01% 1359
2023
Q4
$333K Buy
+38,489
New +$299K ﹤0.01% 1743

Other funds holding CLBT

SG Americas Securities's CLBT Position: Q2 2026 in Review

SG Americas Securities opened a new position in Cellebrite (CLBT) in Q2 2026: 16,051 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #2722 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in CLBT as recently as Q3 2025.

SG Americas Securities first reported a position in CLBT in Q4 2023 and has held it in 9 quarters since. The position peaked at $5.95M in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • SG Americas Securities held 16,051 shares of Cellebrite worth $234K as of Q2 2026.
  • Cellebrite was a new SG Americas Securities position in Q2 2026.
  • Cellebrite made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2722 holding.
  • SG Americas Securities first reported a position in Cellebrite in Q4 2023 and has held it in 9 quarters since.
  • SG Americas Securities's Cellebrite position peaked at $5.95M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.